Other conditions & injuries

Squamous cell carcinoma in horses: persistent sores, eye lesions and genital tumors

Squamous cell carcinoma is a malignant tumor arising from surface epithelial cells. In horses it commonly affects the eye region, lightly pigmented skin and external genital tissues, though other sites occur. A persistent ulcer, rough growth, recurrent bleeding or unexplained eye discharge needs examination and often tissue diagnosis. Early treatment can preserve function; deeper invasion or spread changes the prognosis and treatment options.

Updated 1,012 words · 5 min read5 sources · scope listed below
A horse in a fenced pasture

A horse in a fenced pasture. Species or setting illustration; this is not a photograph of a diagnosed case or of the reader’s animals. Credit and license details are linked below.

Parco Naturale Tre Cime horses 3.jpg · kallerna · CC BY-SA 4.0 · Full credit & reuse terms

Reading the sources

This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.

A nonhealing sore can be a tumor rather than a stubborn wound

SCC can begin as a small rough, scaly or inflamed area and progress to an ulcerated or protruding mass. Its surface may bleed, crust or develop secondary infection. The absence of a large obvious lump does not exclude clinically important disease.

This tumor is different from a sarcoid, even when both resemble proud flesh. SCC arises from epithelial tissue and can invade locally or spread, including to regional lymph nodes. Tumor site and extent matter: a small superficial eyelid lesion, a deeper penile tumor and an internal gastrointestinal cancer are not equivalent prognostic situations. The word skin cancer should not obscure those distinctions.

Source: Squamous cell carcinoma; Skin tumors in horses.

Sunlight and pigmentation matter, but they do not explain every site

Ultraviolet exposure is an important risk for sun-exposed, poorly pigmented tissues. Older horses are commonly affected, and nonpigmented areas around the eye deserve particular attention. Dark pigmentation reduces some risk but does not make a horse incapable of developing SCC.

Genetic susceptibility contributes to ocular disease in some breeds. A DDB2 variant has been associated with elevated risk in particular populations, including Haflingers and Belgians, with additional breed evidence. The result is a risk assessment, not a diagnosis of cancer or a prediction that every carrier will develop a tumor. It also does not explain every SCC at every body site.

Source: Ocular squamous cell carcinoma; DDB2 genetic risk factor for ocular squamous cell carcinoma identified in three additional horse breeds.

Eye discharge can precede an easily visible mass

SCC can affect the eyelids, third eyelid, conjunctiva or corneal region. A pink raised area, persistent discharge, recurrent scabbing or a small bleeding eyelid lesion may be the first clue. Tumor growth can eventually threaten vision and destroy adjacent structures.

A painful, squinting or cloudy eye needs prompt assessment regardless of whether cancer is suspected. Ulceration, infection and uveitis are other urgent possibilities. Do not apply an old eye ointment, a skin-tumor preparation or a caustic remedy to an uncertain lesion. The treatment must preserve the cornea and normal eyelid function as well as control tumor tissue.

Source: Ocular neoplasia in horses; Ocular squamous cell carcinoma.

Genital lesions deserve examination rather than cosmetic cleaning alone

A penile or sheath lesion may cause bleeding, foul-smelling discharge, ulceration or difficulty with normal urination. Other conditions can also produce these signs, so appearance alone is not proof of cancer. A horse unable to urinate normally needs urgent veterinary attention.

These areas are easy to overlook during ordinary grooming, particularly in a horse that is difficult to handle. Competent veterinary examination may require sedation and safe access. Owners should not force the penis out, cut a growth or apply wart remedies. A persistent lesion merits an anatomical diagnosis and assessment of whether deeper structures are involved.

Source: Skin tumors in horses; Squamous cell carcinoma.

Tissue diagnosis and staging guide a realistic treatment choice

Biopsy or examination of an excised lesion identifies the tumor. The clinician also assesses local invasion and, when indicated, regional lymph nodes or other sites. Finding SCC in a small surface sample does not by itself show the full extent of the disease beneath it.

Discuss whether treatment aims for complete local control, preservation of a particular structure or palliation. Depending on site and size, surgery may be combined with selected local or specialist therapy. An eye-region lesion can require an ophthalmologist, while extensive genital disease may require a different surgical assessment. The practical question is what function can be preserved with an acceptable chance of durable comfort.

Source: Skin tumors in horses; Ocular neoplasia in horses; Squamous cell carcinoma.

Early intervention generally offers more choices than waiting

Small lesions can be easier to remove while preserving surrounding tissue. Larger or recurrent tumors may need more extensive treatment, and spread can limit curative options. A reduction in surface inflammation does not prove that the malignant cells have disappeared.

After treatment, reassess both healing and recurrence. Persistent discharge, renewed bleeding or a new lump near the original site deserves review. Long-term follow-up depends on the site and original extent, not a single universal interval. Some horses maintain excellent comfort after treatment, while advanced disease may require palliation or euthanasia when function and pain cannot be adequately managed.

Source: Skin tumors in horses; Squamous cell carcinoma; Ocular neoplasia in horses.

Risk reduction supports early recognition rather than guaranteeing prevention

Provide usable shade and appropriate UV protection for susceptible eye regions, with a well-fitting mask that does not rub. Continue normal inspection of eyelids and other vulnerable sites; protection from sunlight does not replace examination of a persistent lesion.

For a breed in which the DDB2 test is informative, discuss the result with the veterinarian and genetics laboratory when planning eye surveillance or breeding. A negative result does not remove all cancer risk. Balanced prevention combines the relevant inherited risk, environmental exposure and early clinical assessment rather than relying on one gene test or one protective product.

Source: Ocular squamous cell carcinoma; DDB2 genetic risk factor for ocular squamous cell carcinoma identified in three additional horse breeds; Ocular neoplasia in horses.

Practical questions

Does a scabby eyelid lesion have to be large before it matters?

No. A small lesion can still threaten important tissue and should be examined if persistent or recurrent.

Does a DDB2 risk result mean my horse has cancer?

No. It identifies increased inherited risk in relevant populations and supports an appropriate surveillance discussion.

Can antibiotics cure an infected-looking tumor?

They may address secondary infection, but they do not establish control of the underlying malignant growth.

Related animal-health reading

Cite this reference

LivestockDefense. “Squamous cell carcinoma in horses: persistent sores, eye lesions and genital tumors.” Updated 2026-11-02. https://livestockdefense.com/threats/equine-squamous-cell-carcinoma/

Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.

How to cite a page and its revision ↗

Sources & boundaries

Read the evidence in context.

These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.

  1. American College of Veterinary Surgeons: Skin tumors in horses

    Source update: Not provided. Most recent check: 2026-11-02.

    Signs prompting assessment, diagnosis, site-specific treatment and aftercare; excludes surgical methods and does not generalize sarcoid metastasis.

  2. UC Davis Center for Equine Health: Squamous cell carcinoma

    Source update: 2024-11-26. Most recent check: 2026-11-02.

    Equine SCC sites, invasion, UV and individualized diagnosis/treatment; original clinical summary.

  3. UC Davis Center for Equine Health: Ocular squamous cell carcinoma

    Source update: 2019-10-18. Most recent check: 2026-11-02.

    Ocular recognition, UV/pigment risk, genetic context and early diagnosis; no ocular procedures.

  4. Genes / primary veterinary genetic study: DDB2 genetic risk factor for ocular squamous cell carcinoma identified in three additional horse breeds

    Source update: 2020. Most recent check: 2026-11-02.

    Breed/phenotype-specific genetic risk, not deterministic diagnosis or universal explanation of all equine SCC; no genetic assay procedures.

  5. Merck Veterinary Manual: Ocular neoplasia in horses

    Source update: 2024-09. Most recent check: 2026-11-02.

    Ocular SCC risks and local invasion/diagnostic context, excluding surgery and topical drug procedures.

Full source register ↗